Skip to main content

Effient News

FDA Medwatch Alert: Long-term Antiplatelet Therapy: Safety Announcement - Preliminary Trial Data Shows Benefits But a Higher Risk of Non-Cardiovascular Death

[Posted 11/16/2014] ISSUE: FDA is evaluating preliminary data from a clinical trial showing that treatment for 30 months with dual antiplatelet blood-thinning therapy decreased the risk of heart...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Myocardial Infarction, Heart Attack

Effient patient information at Drugs.com